
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate Equities Inc. is strategically positioned in high-demand markets, including Greater Boston and the San Francisco Bay Area, serving tenants in the thriving life science, agtech, and technology sectors. The company benefits from strong public sector investment, which is expected to bolster demand in the engineering and construction sectors, further enhancing rental growth and net absorption in its portfolio. Additionally, Alexandria's impressive backlog of $10.8 billion, coupled with a more favorable environment for biotech valuations, suggests significant potential for capital formation, tenant growth, and sustained profitability moving forward.
Bears say
Alexandria Real Estate's stock faces a negative outlook due to a confluence of unfavorable financial indicators, including a projected decline in occupancy rates and slower leasing activity driven by stagnating demand from life science tenants. The company has experienced operational challenges, such as an operating loss associated with legacy projects and reduced earnings estimates, highlighting an accelerated burn-off of capitalized interest and difficulties in capital formation within the life science sector. Furthermore, an oversupply of life science properties and significant constraints from government regulations and funding limitations are anticipated to adversely affect Alexandria's revenue growth and overall financial health in the coming years.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares